Top Tweets for #longevityproject
Are you signed up to our #LONGEVITYproject mailing list?
LONGEVITY is working to bring long-acting options for malaria, TB and HCV to people in LMICs where the burden of these three diseases is largest.
July is a newsletter month, the next email is soon:
https://t.co/VccAttDO5r
🧵2/2
The #LONGEVITYproject is a consortium, funded by global health agency @UNITAID, working to bring long-acting tuberculosis and malaria preventative and a one-shot-cure for hepatitis C virus to patients in low- and middle- income countries.
🧵1/2
We send a quarterly #LONGEVITYproject newsletter in case you missed any of our news from the last few months.
We use it to update you on news, LONGEVITY relevant events and any upcoming opportunities.
If you aren't subscribed, you can sign up here: https://t.co/VccAttDgfT
#LONGEVITYproject is a consortium working to make long-acting malaria and tuberculosis preventatives, and a one-shot cure for patients with hepatitis C virus.
We explain more about LONGEVITY on our website, including pages about the work for each disease:
https://t.co/8xyWr2zEIp
@CELTLiverpool @UNITAID Staying informed strengthens action.
The #LONGEVITYproject newsletter connects research, updates, and opportunities shaping longer, healthier lives.
🧵1/4
We're trying to make sure our work on the #LONGEVITYproject is as transparent as possible.
Funded by @UNITAID, we've created a breakdown of what the work for each disease looks like.
We hope an accessible explanation will help show the journey of each disease.
@CELTLiverpool @UNITAID Stay updated on long-acting TB, hepatitis C, and malaria treatments in LMICs.
Subscribe to the #LONGEVITYproject newsletter.
Are you subscribed to our #LONGEVITYproject newsletter?
It's a quarterly update of the international consortium work (funded by @UNITAID) to bring long-acting treatments or preventatives to patients with tuberculosis, hepatitis C virus and malaria in LMICs
https://t.co/VccAttDgfT
Wakati nasoma kitabu hiki cha “The Village Effect” nilichokiazima @UONGOZI, nimekutana na simulizi zuri la #LongevityProject, mradi uliongozwa na washunuzi wa Chuo Kikuu cha California, Howard Friedman na Leslie Martin, uliofuatilia watu zaidi ya 1,500 wenye uwezo mkubwa wa akili (wengi wao waliochaguliwa na Lewis Terman mwaka 1921).
Ilibidi niusome mradi huo kidogo kujifunza —na kumbe kuna hadi kitabu kabisa kimeandikwa. Tafiti za wenzetu zinajitahidi kwenda mbali ikiwa ni pamoja na kutokukwepa gharama ya kufuatilia data kwa muda mrefu.
Friedman na Martin waligundua kuwa katika hao waliowafuatilia, walioishi maisha marefu zaidi ni wale wanaoishi maisha yenye utulivu, wanaojua wanachokifanya, wanaojituma na kutia bidii katika lile wanalolifanya (conscientiousness). Lakini kubwa zaidi, wakagundua, watu wenye mtandao mkubwa na unaoaminika wa familia, marafiki na jamii kwa upana wake; watu wanaoaminiana na kusaidiana na wengine waliishi maisha marefu zaidi.
Kwa kifupi, ukitaka kuongeza uwezekano wa kuishi maisha marefu (tukiweka pembeni sababu nyinginezo), usiache zile tabia za kijijini —kuwa karibu na watu, kutojipa hadhi inayokukinga usijichanganye na watu, pale unapoweza rudisha tabasamu la mtu kwa kumsaidia kutatua shida yake na kadri inavyowezekana punguza kujifanya wewe ni jeshi la mtu mmoja na huhitaji watu.
Next week is our quarterly #LONGEVITYproject newsletter.
This quarter includes:
- Work from partners @TAGTeam_Tweets and @CHAI_health.
- Recent hepatitis C virus proof of concept announcement
- Community of Practice meeting highlights
Subscribe: https://t.co/FDdeYnVfDX
@UNITAID
17 September is #InternationalMicroorganismDay and @WHO's #PatientSafetyDay.
We're highlighting #LONGEVITYproject. Explore the impact of the project diseases (HCV, malaria and TB) and our long-acting options work to keep LMIC patients safe from them.
https://t.co/j7BRxbqNDp
Are you signed up to our quarterly #LONGEVITYproject newsletter?
We share news, events and opportunities in our international consortium and partners' work towards creating long-acting therapeutics for HCV, malaria and TB in LMICs.
Subscribe here: https://t.co/FDdeYnUHOp
12 December is @UN's International Universal Health Coverage Day.
The #LONGEVITYProject is researching long-acting medical options for hepatitis C virus, malaria and tuberculosis in LMICs, to help the UN's commitment to move the world towards UHC by 2030.
https://t.co/j7BRxbqfNR
NEWS!
#LONGEVITYproject paper has been published in the Journal of Viral Hepatitis showing patients in LMICs are enthusiastic about long-acting injections to treat hepatitis C virus.
78% of 400 participants are willing to receive long-acting HCV medicine.
https://t.co/M7o2qaSFxF
The #LONGEVITYproject, funded by @UNITAID, is an international consortium spanning the journey from idea to manufacture of long-acting therapeutics for malaria, TB and hepatitis C virus in low- and middle- income countries where the burden is highest.
https://t.co/j7BRxbqfNR
The second #LONGEVITYproject partner blog series celebrates teams delivering our research.
LONGEVITY is working to provide long-acting therapeutic options in LMICs for malaria, TB and hepatitis C virus, and the research partners are the key foundation.
👉https://t.co/iol2YVVtWO
Today is #WorldMosquitoDay
#Malaria is a life threatening disease caused by a parasite mosquitoes transmit. It disproportionately impacts LMICs, especially children
The #LONGEVITYproject strives to provide long-acting malaria prevention options to LMICs
👉https://t.co/iVOMIr2tFZ
28 July was #WorldHepatitisDay, as coined by @Hep_Alliance
We recently presented a breakthrough in the #LONGEVITYproject's hepatitis C virus long-acting treatment research, putting us one step closer to a test-and-cure option for HCV
https://t.co/xLDGi0sSoN
#WorldHepatitisDay2024
Have you subscribed to our quarterly #LONGEVITYproject newsletter?
Sign up via the link below to stay connected to our work researching long-acting therapeutic options for malaria, tuberculosis and hepatitis C virus in low- and middle- income countries.
👉https://t.co/VQMNhVpOzi
We'll soon be sending out our #LONGEVITYproject quarterly newsletter (funded by @UNITAID), so there's still time to subscribe if you haven't yet.
This issue includes community engagement news, a malaria scope update, and more.
Sign up here
👉https://t.co/VQMNhVpOzi
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.9M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Cristiano Ronaldo
@cristiano
111.6M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.9M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.1M followers
KATY PERRY
@katyperry
88.2M followers
Taylor Swift
@taylorswift13
82.1M followers
Lady Gaga
@ladygaga
73.6M followers
Virat Kohli
@imvkohli
70.7M followers
Kim Kardashian
@kimkardashian
70M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.2M followers
Neymar Jr
@neymarjr
63.6M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.3M followers
X
@x
60.8M followers